Mr. Elliot McKerr reports

HYTN ANNOUNCES EXTENSION OF MARKETING PROGRAM

Further to the news releases on Jan. 9, 2026, March 2, 2026, and March 20, 2026, HYTN Innovations Inc. is extending its engagement of MCS Market Communication Service GmbH to provide certain marketing and communications services. The engagement is expected to commence on April 24, 2026, and continue for a period of approximately 60 days, or until the allocated budget is exhausted, subject to earlier termination or extension at the discretion of the company.

The services to be provided by MCS are expected to include the development of digital content and advertising materials, keyword optimization, project co-ordination, and media distribution services, with the objective of increasing general awareness of the company and its business. MCS will execute these services through on-line platforms using demographic, geographic, keyword and interest-based targeting to reach relevant investor audiences.

MCS is arm's length to the company. In consideration for the services, the company has agreed to pay 100,000 euros to MCS. No securities of the company will be issued as compensation, and, to the knowledge of the company, neither MCS nor any of its principals hold any securities of the company.

About HYTN Innovations Inc.

HYTN Innovations is a pharmaceutical company specializing in the formulation, manufacturing, marketing and sale of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids. The company focuses on serving federally regulated markets by applying pharmaceutical-grade development, manufacturing and quality systems. HYTN advances products to market by identifying regulated market opportunities and leveraging its integrated development and commercialization platform.

We seek Safe Harbor.